Epstein–Barr virus-mediated transformation of B cells induces global chromatin changes independent to the acquisition of proliferation

Epstein–Barr virus (EBV) infects and transforms human primary B cells inducing indefinite proliferation. To investigate the potential participation of chromatin mechanisms during the EBV-mediated transformation of resting B cells we performed an analysis of global changes in histone modifications. We observed a remarkable decrease and redistribution of heterochromatin marks including H4K20me3, H3K27me3 and H3K9me3. Loss of H4K20me3 and H3K9me3 occurred at constitutive heterochromatin repeats. For H3K27me3 and H3K9me3, comparison of ChIP-seq data revealed a decrease in these marks in thousands of genes, including clusters of HOX and ZNF genes, respectively. Moreover, DNase-seq data comparison between resting and EBV-transformed B cells revealed increased endonuclease accessibility in thousands of genomic sites. We observed that both loss of H3K27me3 and increased accessibility are associated with transcriptional activation. These changes only occurred in B cells transformed with EBV and not in those stimulated to proliferate with CD40L/IL-4, despite their similarities in the cell pathways involved and proliferation rates. In fact, B cells infected with EBNA-2 deficient EBV, which have much lower proliferation rates, displayed similar decreases for heterochromatic histone marks. Our study describes a novel phenomenon related to transformation of B cells, and highlights its independence of the pure acquisition of proliferation.

[1]  Manel Esteller,et al.  Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin , 2005, Nature Cell Biology.

[2]  Nuria Lopez-Bigas,et al.  Gitools: Analysis and Visualisation of Genomic Data Using Interactive Heat-Maps , 2011, PloS one.

[3]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[4]  G. Almouzni,et al.  Replication stress interferes with histone recycling and predeposition marking of new histones. , 2010, Molecular cell.

[5]  G. Hong,et al.  Nucleic Acids Research , 2015, Nucleic Acids Research.

[6]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Pender.  Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. , 2003, Trends in immunology.

[8]  E. Kieff,et al.  Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.

[9]  Tatiana Nikitina,et al.  Dynamic relocation of epigenetic chromatin markers reveals an active role of constitutive heterochromatin in the transition from proliferation to quiescence , 2004, Journal of Cell Science.

[10]  W. Hammerschmidt,et al.  Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Hammerschmidt,et al.  Epstein–Barr virus‐mediated B‐cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor , 1998, The EMBO journal.

[12]  Chen Zeng,et al.  A clustering approach for identification of enriched domains from histone modification ChIP-Seq data , 2009, Bioinform..

[13]  Dirk Schübeler,et al.  Nuclear compartmentalization and gene activity , 2000, Nature Reviews Molecular Cell Biology.

[14]  Yipeng Wang,et al.  Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. , 2010, Blood.

[15]  D. Reinberg,et al.  Facultative heterochromatin: is there a distinctive molecular signature? , 2007, Molecular cell.

[16]  M. Fraga,et al.  Combinatorial effects of splice variants modulate function of Aiolos , 2007, Journal of Cell Science.

[17]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.

[18]  J. Yu,et al.  Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Pawlita,et al.  Epstein‐Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c‐myc gene in Burkitt's lymphoma cells. , 1996, The EMBO journal.

[20]  James Allan,et al.  DNA methylation affects nuclear organization, histone modifications, and linker histone binding but not chromatin compaction , 2007, The Journal of cell biology.

[21]  Esteban Ballestar,et al.  Methyl‐CpG binding proteins identify novel sites of epigenetic inactivation in human cancer , 2003, The EMBO journal.

[22]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[23]  Fatima Al-Shahrour,et al.  The B cell transcription program mediates hypomethylation and overexpression of key genes in Epstein-Barr virus-associated proliferative conversion , 2013, Genome Biology.

[24]  I. Magrath.  Epidemiology: clues to the pathogenesis of Burkitt lymphoma , 2012, British journal of haematology.

[25]  E. Robertson,et al.  Epstein-Barr Virus–Associated B-cell Lymphomas: Pathogenesis and Clinical Outcomes , 2011, Clinical Cancer Research.

[26]  Y. Song,et al.  Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications , 2010, Carcinogenesis.

[27]  Mark I McCarthy,et al.  Variability of gene expression profiles in human blood and lymphoblastoid cell lines , 2010, BMC Genomics.

[28]  A. Taylor,et al.  Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. , 2007, Blood.

[29]  T. Piolot,et al.  Live-Cell Imaging Reveals Multiple Interactions between Epstein-Barr Virus Nuclear Antigen 1 and Cellular Chromatin during Interphase and Mitosis , 2012, Journal of Virology.

[30]  M. Fraga,et al.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.

[31]  Y. Usson,et al.  1q12 chromosome translocations form aberrant heterochromatic foci associated with changes in nuclear architecture and gene expression in B cell lymphoma , 2010, EMBO molecular medicine.

[32]  R. Sompallae,et al.  The Epstein–Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins , 2013, Nucleic acids research.

[33]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[34]  R. Feederle,et al.  Epstein-Barr virus genetics: talking about the BAC generation , 2010, Herpesviridae.

[35]  Y. Sheng,et al.  EBNA1-Mediated Recruitment of a Histone H2B Deubiquitylating Complex to the Epstein-Barr Virus Latent Origin of DNA Replication , 2009, PLoS pathogens.

[36]  M. Masucci,et al.  Interaction of Gamma-Herpesvirus Genome Maintenance Proteins with Cellular Chromatin , 2013, PloS one.

[37]  K. Helin,et al.  The H3K27me3 demethylase, KDM6B, is induced by Epstein–Barr virus and over-expressed in Hodgkin's Lymphoma , 2011, Oncogene.

[38]  Henriette O'Geen,et al.  Genome-Wide Analysis of KAP1 Binding Suggests Autoregulation of KRAB-ZNFs , 2007, PLoS genetics.

[39]  Gordon B Mills,et al.  Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers , 2008, Molecular carcinogenesis.

[40]  P. Farrell,et al.  The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus. , 1995, Cancer research.

[41]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[42]  E. Kieff,et al.  Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  L. Staudt,et al.  Pathogenesis of human B cell lymphomas. , 2012, Annual review of immunology.

[44]  Andreas Prlic,et al.  Ensembl 2007 , 2006, Nucleic Acids Res..